Greenland Mines Ltd. Common Stock (NASDAQ:GRML) Releases Quarterly Earnings Results

Greenland Mines Ltd. Common Stock (NASDAQ:GRML) released its quarterly earnings results on Wednesday. The company reported ($0.15) EPS for the quarter, FiscalAI reports.

Greenland Mines Ltd. Common Stock Stock Down 0.1%

Shares of GRML opened at $0.39 on Friday. The firm has a 50-day moving average price of $0.49 and a 200 day moving average price of $0.42. The firm has a market capitalization of $47.08 million, a PE ratio of -1.55 and a beta of 7.61. Greenland Mines Ltd. Common Stock has a 52-week low of $0.16 and a 52-week high of $3.91.

Analyst Upgrades and Downgrades

GRML has been the subject of several recent research reports. Wall Street Zen upgraded shares of Greenland Mines Ltd. Common Stock to a “sell” rating in a research report on Saturday, May 2nd. Weiss Ratings reiterated a “sell (e+)” rating on shares of Greenland Mines Ltd. Common Stock in a research report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Greenland Mines Ltd. Common Stock has a consensus rating of “Sell”.

Hedge Funds Weigh In On Greenland Mines Ltd. Common Stock

Institutional investors and hedge funds have recently bought and sold shares of the stock. Jane Street Group LLC bought a new position in Greenland Mines Ltd. Common Stock in the 2nd quarter valued at about $26,000. XTX Topco Ltd lifted its holdings in Greenland Mines Ltd. Common Stock by 101.2% in the 4th quarter. XTX Topco Ltd now owns 160,569 shares of the company’s stock valued at $46,000 after acquiring an additional 80,768 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in Greenland Mines Ltd. Common Stock in the 4th quarter valued at about $126,000. Geode Capital Management LLC lifted its holdings in Greenland Mines Ltd. Common Stock by 51.8% in the 4th quarter. Geode Capital Management LLC now owns 491,832 shares of the company’s stock valued at $142,000 after acquiring an additional 167,905 shares during the last quarter. Finally, Brummer Multi Strategy AB acquired a new stake in Greenland Mines Ltd. Common Stock in the 4th quarter valued at about $175,000. Institutional investors own 20.07% of the company’s stock.

Greenland Mines Ltd. Common Stock Company Profile

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases – cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.